Pencarian obat berdasarkan namanya

Lorazepam Oral Concentrate dan Kejang

Hasil pengujian interaksi obat Lorazepam Oral Concentrate dan penyakit Kejang untuk kontraindikasi dan efek samping dengan penggunaan bersama.

Hasil pengecekan:

Lorazepam Oral Concentrate <> Kejang

Aktualitas: 23.07.2019 Pemeriksa: Dr. P.M.Shkutko, in

Sesuai dengan informasi sumber yang dapat diandalkan Drugs.com, Rxlist.com, Webmd.com, Medscape.com, saat pemeriksaan interaksi efek samping dan kontraindikasi ditemukan, yang dapat membahayakan atau meningkatkan efek negatif saat penggunaan kombinasi obat-obatan dengan penyakit yang terkait.

Konsumen:

Penggunaan benzodiazepin pada pasien dengan gangguan kejang dapat meningkatkan kejadian atau memicu timbulnya kejang umum tonik-klonik (grand mal). Tepat obat antikonvulsan mungkin perlu dimulai atau dosis ditingkatkan. Penghentian mendadak terapi benzodiazepin dapat memicu kejang dan gejala penarikan lainnya, terutama setelah penggunaan jangka panjang dan/atau dosis yang berlebihan. Status epileptikus dapat terjadi pada pasien dengan riwayat kejang ditarik dengan cepat dari benzodiazepine terapi. Berikut kronis administrasi, penghentian benzodiazepin terapi harus terjadi secara bertahap dengan secara bertahap mengurangi dosis. Pasien harus disarankan untuk tidak menghentikan pengobatan tanpa konsultasi terlebih dahulu dengan dokter.

Sumber

Berlin RM, Conell LJ "Withdrawal symptoms after long-term treatment with therapeutic doses of flurazepam: a case report." Am J Psychiatry 140 (1983): 488-90
Tien AY, Gujavarty KS "Seizure following withdrawal from triazolam." Am J Psychiatry 142 (1985): 1516-7
Browne JL, Hauge KJ "A review of alprazolam withdrawal." Drug Intell Clin Pharm 20 (1986): 837-41
"Product Information. Doral (quazepam)." Wallace Laboratories, Cranbury, NJ.
"Product Information. ProSom (estazolam)." Abbott Pharmaceutical, Abbott Park, IL.
"Product Information. Versed (midazolam)." Roche Laboratories, Nutley, NJ.
"Product Information. Dalmane (flurazepam)." Roche Laboratories, Nutley, NJ.
MacKinnon GL, Parker WA "Benzodiazepine withdrawal syndrome: a literature review and evaluation." Am J Drug Alcohol Abuse 9 (1982): 19-33
"Product Information. Valium (diazepam)." Roche Laboratories, Nutley, NJ.
Busto U, Sellers EM, Naranjo CA, et al "Withdrawal reaction after long-term therapeutic use of benzodiazepines." N Engl J Med 315 (1986): 854-9
Roy-Byrne PP, Sullivan MD, Cowley DS, Ries RK "Adjunctive treatment of benzodiazepine discontinuation syndromes - a review." J Psychiatr Res 27 Suppl (1993): 143-53
Petursson H, Lader MH "Benzodiazepine dependence." Br J Addict 76 (1981): 133-45
Howe JG "Lorazepam withdrawal seizures." Br Med J 280 (1980): 1163-4
Ghadirian AM, Gauthier S, Wong T "Convulsions in patients abruptly withdrawn from clonazepam while receiving neuroleptic medication ." Am J Psychiatry 144 (1987): 686
Bond WS, Schwartz M "Withdrawal reactions after long-term treatment with flurazepam." Clin Pharm 3 (1984): 316-8
"Product Information. Serax (oxazepam)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
"Product Information. Halcion (triazolam)." Pharmacia and Upjohn, Kalamazoo, MI.
Wilbur R, Kulik AV "Abstinence syndrome from therapeutic doses of oxazepam." Can J Psychiatry 28 (1983): 298-300
Hersch EL, Billings RF "Acute confusional state with status petit mal as a withdrawal syndrome: and five year follow-up." Can J Psychiatry 33 (1988): 157-9
Robinson GM, Sellers EM "Diazepam withdrawal seizures." Can Med Assoc J 126 (1982): 944-5
Schneider LS, Syapin PJ, Pawluczyk S "Seizures following triazolam withdrawal despite benzodiazepine treatment." J Clin Psychiatry 48 (1987): 418-9
"Product Information. Xanax (alprazolam)." Pharmacia and Upjohn, Kalamazoo, MI.
"Product Information. Klonopin (clonazepam)." Roche Laboratories, Nutley, NJ.
Finley PR, Nolan PE, Jr "Precipitation of benzodiazepine withdrawal following sudden discontinuation of midazolam." DICP 23 (1989): 151-2
Kales A, Bixler EO, Soldatos CR, Jacoby JA, Kales JD "Lorazepam: effects on sleep and withdrawal phenomena." Pharmacology 32 (1986): 121-30
Hauser P, Devinsky O, De Bellis M, Theodore WH, Post RM "Benzodiazepine withdrawal delirium with catatonic features. Occurrence in patients with partial seizure disorders." Arch Neurol 46 (1989): 696-9
Ryan GP, Boisse NR "Experimental induction of benzodiazepine tolerance and physical dependence." J Pharmacol Exp Ther 226 (1983): 100-7
Ananth J "Abstinence syndrome from therapeutic doses of oxazepam." Can J Psychiatry 28 (1983): 592
"Product Information. Tranxene (clorazepate)." Abbott Pharmaceutical, Abbott Park, IL.
"Product Information. Librium (chlordiazepoxide)." Roche Laboratories, Nutley, NJ.
"Product Information. Ativan (lorazepam)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
Frattola L, Garreau M, Piolti R, Bassi S, Albizzati MG, Borghi C, Morselli PL "Comparison of the efficacy, safety and withdrawal of alpidem and alprazolam in anxious patients." Br J Psychiatry 165 (1994): 94-100
Alvarez N, Hartford E, Doubt C "Epileptic seizures induced by clonazepam." Clin Electroencephalogr 12 (1981): 57-65
Specht U, Boenigk HE, Wolf P "Discontinuation of clonazepam after long-term treatment." Epilepsia 30 (1989): 458-63
Patterson WM "Triazolam withdrawal." J Clin Psychiatry 49 (1988): 369
"Product Information. Restoril (temazepam)." Sandoz Pharmaceuticals Corporation, East Hanover, NJ.